The S&P/ASX 200 Index (ASX: XJO) is down 0.3% in early trade today, but that’s not holding back ASX 200 uranium stock Boss Energy Ltd (ASX: BOE).

Shares in the Aussie uranium producer closed yesterday trading at $4.08. At time of writing on Friday morning, shares are swapping hands for $4.22 apiece, up 3.5%.

This comes following news that Boss Energy’s second uranium project has kicked off production.

Here’s what’s happening.

ASX 200 uranium stock lifts off on production milestone

The Boss Energy share price is charging higher after the company announced that production has started at its Alta Mesa In-Situ Recovery (ISR) Central Processing Uranium Plant and Wellfields, located in the US state of Texas.

The ASX 200 uranium stock owns 30% of the project. Its joint venture (JV) partner, enCore Energy Corp (NASDAQ: EU), owns the other 70%.

The Alta Mesa Project comprises more than 200,000 acres, along with the central processing plant and wellfields. Boss Energy expects production at the project to ramp up to a steady-state rate of 1.5 million pounds per year.

Today’s announcement comes just eight weeks after Boss Energy kicked off production at its 100%-owned Honeymoon project in South Australia. Honeymoon’s production is forecast to ramp up to 2.45 million pounds per year.

Commenting on the milestone sending the ASX 200 uranium stock sharply higher today, Boss Energy managing director Duncan Craib said, “The start of production at the Alta Mesa Project is another key milestone in the implementation of our strategy to be a global uranium supplier with a diversified production base in tier-one locations.”

Craib added:

With operations now ramping up at both Honeymoon and Alta Mesa, we are on track to hit our combined nameplate production target of 3 million pounds of uranium per annum. Our timing could hardly be better given the increasingly tight supply and demand fundamentals in the uranium market.

This highly favourable outlook was underpinned by US President Joe Biden’s recent signing of legislation to ban the importation of uranium products from Russia. This was a game-changing event for the uranium market and in particular for uranium projects in North America and Australia.

Craib said that with the ASX 200 uranium stock ramping up production at Honeymoon and Alta Mesa and both projects enjoying strong growth prospects, Boss was “very well positioned to continue capitalising on this huge opportunity”.

The post Why is ASX 200 uranium stock Boss Energy flying higher on Friday? appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Insiders are buying these 6 ASX All Ords shares
• Why Boss Energy, Elders, Peter Warren, and Serko shares are sinking today
• ASX 200 uranium stock dives 10% amid $26 million insiders sell-off
• ASX 200 shares vs. property: Which has performed better since the COVID crash?

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Investing in the stock market can feel like navigating a jungle – thrilling but sometimes overwhelming.

However, there’s a trusty compass to help guide your way: strong cash flows. Companies with robust cash flows are like the steady heartbeats of the stock market, providing the lifeblood that fuels growth, innovation, and shareholder returns.

In this article, we’ll introduce you to two ASX shares with impressive cash flows, making them prime candidates for your investment portfolio today.

Whether you’re a seasoned investor or just starting, these cash flow champions are worth your attention. Let’s dive in and explore my two ASX stock picks below.

Super Retail Group Ltd (ASX: SUL)

Super Retail is a prominent retailing group in Australia and New Zealand, specialising in automotive, sports, and outdoor leisure products. The company operates several well-known brands, including Supercheap Auto, Rebel, BCF, and Macpac.

Established in 1972, Super Retail has grown significantly, offering a diverse range of products to meet the needs of enthusiasts and professionals alike.

The retailer generated cash flow from operations of $756 million over the last 12 months to December 2023. From here, the company paid for its capital expenditure of $155 million, which increased from $110 million in FY23 used to expand its store network in Supercheap Auto and Rebel in the main.

This leaves the company with a free cash flow of approximately $600 million, sufficient to cover its lease payment obligations of around $220 million.

Compared to its current market capitalisation of close to $3 billion, Super Retail offers a free cash flow yield of more than 13% even after considering the lease payments.

Goldman Sachs also recognised this potential investment opportunity. As my colleague James highlighted, Goldman Sachs included Super Retail as one of its top dividend shares to buy. The broker said:

We believe SUL will display resilience in a softer economic environment that is built upon its competitive advantage of high loyalty (~11.0m active members accounting for >75% of sales) and this will be further bolstered as the company launches the Rebel loyalty program and continues to build personalisation capabilities. Hence, we are Buy-rated on SUL.

The Super Retail share price has fallen almost 23% from its all-time high of $17.11 in February 2024.

NIB Holdings Limited (ASX: NHF)

NIB is an Australian health insurer that provides health and medical insurance products to Australian and New Zealand residents, as well as international students and workers.

Founded in 1952, NIB has expanded its services to include travel and life insurance. The company focuses on providing affordable and comprehensive coverage, leveraging digital platforms to enhance customer experience and accessibility.

For the last 12 months to December 2023, NIB generated a cash flow from operations of $304.4 million, which has increased over the previous five years from $180 million in FY18.

The company explained that policyholder growth across its businesses underscored its strong operating cash inflow. NIB Thrive and Midnight Health are growing at a healthy rate, more than offsetting a sluggish result from NIB Travel.

From the operating cash flow, the company paid for property and other capital expenditures of around $50 million, leaving approximately $250 million as a free cash flow.

Based on NIB’s current market price, its free cash flow represents around 7% of its current market capitalisation of $3.6 billion. This means that if you acquired the company as a whole today, it would generate about a 7% return in its cash flow, which isn’t too bad, in my view.

Goldman Sachs sees further upside in the NIB share price due to NIB’s policyholder growth, diversified earnings streams, and valuation appeal, as my colleague Zach summarised.

The NIB share price has dropped 14% over the last 12 months and is down just 0.4% year to date.

The post 2 ASX shares with strong cash flows appeared first on The Motley Fool Australia.

More reading

• Goldman Sachs says these 3 ASX dividend shares are buys
• Are these beaten-up ASX shares too cheap to ignore?
• 3 ASX stocks Warren Buffett could buy today
• Analysts name 3 ASX income stocks to buy now
• What are 3 of the safest ASX consumer discretionary shares in Australia right now?

Motley Fool contributor Kate Lee has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Super Retail Group. The Motley Fool Australia has positions in and has recommended Super Retail Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a fall today.

Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed on Tuesday trading for $16.46.

Shares were frozen yesterday after the stock entered a trading halt pending additional details on the company’s proposed initial public offering (IPO) in the United States.

With those details now out, shares are swapping hands for $16.13 apiece at the time of writing, down 2.0%.

Here’s what ASX 200 investors are mulling over.

ASX 200 biotech stock pulls out of Nasdaq IPO

The Telix Pharmaceuticals share price is under pressure after the company announced that its Nasdaq listing is off the cards.

The US listing has been in the works since early January. In May, Telix Pharmaceuticals chair Kevin McCann said the dual listing would enable the ASX 200 biotech stock “to better access the deep pool of specialist investors focused on biotechnology and radiopharmaceuticals in the US”.

He added that the Nasdaq listing would give the company increased visibility which “will drive long-term value creation for shareholders”.

On 6 June, the company confirmed its intent to list American Depositary Shares (ADSs) on the Nasdaq. The Telix Pharmaceuticals share price hit record highs on the day.

Today the company said it opted to withdraw its proposed Nasdaq IPO at the terms provided under current market conditions, adding that the proposed discounts were not aligned with its duty to existing shareholders.

Telix said its plan to list on the Nasdaq wasn’t based on the need to raise capital. And since it first announced its intent to file on 4 January, the company has achieved a number of commercially significant milestones with its medical products. That’s seen the Telix Pharmaceuticals share price soar more than 70% since 4 January.

Commenting on the withdrawal from the Nasdaq IPO, Telix CEO Christian Behrenbruch said:

While this is not our desired outcome Telix’s strategic objectives must align with our duty to existing shareholders. I’d like to thank my team for the personal commitment and incredibly long hours put into this IPO process.

Telix Pharmaceuticals noted that its performance and prospects remain strong.

“As a profitable, cash generative company, Telix retains sufficient earnings and balance sheet capacity to deliver on its key corporate objectives,” the company stated.

Telix Pharmaceuticals share price snapshot

The Telix Pharmaceuticals share price is up 61% so far in 2024.

Long-term investors who bought shares five years ago will be sitting on eye-popping gains of 1,541%.

The post Telix Pharmaceuticals share price sinks on unexpected Nasdaq news appeared first on The Motley Fool Australia.

More reading

• Why this broker just upgraded Telix shares to a buy rating
• Why is the Telix Pharmaceuticals share price frozen today?
• 4 top ASX 200 stocks to buy now for the AI revolution
• 3 ASX 300 healthcare stocks ‘well positioned to outperform’
• 2 ASX biotech shares that could be the next Telix Pharmaceuticals

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Fortescue Ltd (ASX: FMG) shares have been known for huge dividend payouts in the last few years. The outlook for big dividends in the future is not strong, in my opinion.

The ASX iron ore share took full advantage of the elevated iron ore price in FY21, leading to an annual dividend per share of $3.58.

In FY22, the annual dividend per share was reduced to $2.07.

Can the Fortescue dividend recover to above $3 per share? I don’t think it will, for a few different reasons.

Increasing iron ore supply

The key factor enabling Fortescue to generate such a large profit and pay a big dividend in FY21 was the strong iron ore price.

Strong demand from China outstripped supply, leading to a higher commodity price.

I’m not sure the supply and demand equation will work as strongly as it did in Fortescue’s favour in the future.

The Chinese real estate sector is still struggling, so I don’t see this key iron ore user pushing up the iron ore price again like it did. India could be a big user of steel in the coming years, but it’s unlikely to be on the same scale as China.

On the supply side, a significant increase in iron ore mining could be a headwind for the iron ore price. In Africa, Rio Tinto Ltd (ASX: RIO) is part of the huge Simandou iron ore project, and Fortescue Ltd (ASX: FMG) is working on a project in Gabon.

Rio Tinto, Fortescue and BHP Group Ltd (ASX: BHP) all want to increase their production in Australia.

Lower dividend payout ratio

The Fortescue dividend payout ratio has been trending downwards, which means Fortescue is holding onto a larger proportion of its generated profit.

In FY21, Fortescue had a dividend payout ratio of 80%, which fell to 75% in FY22 and then 65% in both FY23 and the first half of FY24. A lower payout ratio obviously means smaller dividends for owners of Fortescue shares.

The business has an important reason to hold onto more of its cash – it has huge green energy ambitions related to green hydrogen, green ammonia, industrial batteries and more. It will need a lot of capital to realise its goals, even if it is successful at bringing on investment partners.

Even if Fortescue were making big enough profits to pay a $3 per share dividend, I don’t think it would be that generous with its dividend in the future because of the capital requirements.

Fortescue dividend projections

The estimate on Commsec for the Fortescue dividend per share in FY24 is $2.02, followed by $1.50 in FY25 and then sinking to $1.08 per share in FY26.

It’s possible the iron ore price may be stronger than expected in the medium term, as it was in FY21 and at the start of this year when it was above US$140 per tonne. But shareholders such as myself should be aware that the payout may not be as rewarding in the future.

The post Why the best dividend days may be over for Fortescue shares appeared first on The Motley Fool Australia.

More reading

• 2 top ASX 200 passive income stocks I’d buy now to boost my retirement
• Here’s the iron ore price forecast through to 2027
• If I buy 1,000 Fortescue shares, how much passive income will I receive?
• How to earn $1,900 in passive income with just $10,000 in savings
• Fortescue shares rally amid claims of green tech theft

Motley Fool contributor Tristan Harrison has positions in Fortescue. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Catapult Group International Ltd (ASX: CAT) has been a standout ASX All Ords stock in the last 12 months, surging 89% to $1.83 currently. This is an 81% advantage over the benchmark S&P/ASX 200 Index (ASX: XJO) in the past year.

It has also been all green for the stock since trading began in January – up 32% year to date.

Despite this impressive gain, many believe this ASX All Ords stock still has room to grow. Let me explain.

What’s driving this ASX All Ords stock?

Catapult’s growth has been driven by strong financial performance and strategic initiatives. For the financial year ending 31 March 2024, the ASX All Ords stock’s revenue reached a milestone of US$100 million, a 20% increase year over year.

This growth reflects the strength of its software as a service (SaaS) strategy, which has been pivotal in attracting new customers and increasing the annualised contract value (ACV).

Forager Funds Management has been optimistic about Catapult’s potential for a long time. In its latest report from May 2024, the firm noted that it hopes “…to be writing about Catapult for years to come. For many years, we have admired the opportunity ahead of this company.”

The fund manager highlighted the ASX All Ord stock’s well-known athlete tracking vests, which are used in various major sports leagues worldwide.

Any avid sports-watcher will be familiar with Catapult’s athlete tracking vests. You can see them through Pat Cummins’ whites on a summer day at the SCG or at a training session for every single NRL and AFL team in Australia.

Forager also praised Catapult’s strategic vision under CEO Will Lopes. “When appointed in 2021, CEO Will Lopes didn’t do much to change the perception that shareholders would never see potential translate to profits”, it said.

But three years later, it says Lopes was right, that Catapult “needed to spend more”, and “needed to spend first”. Forager believes he is the “right man” to do the job.

The share price has reacted positively to the past few results announcements from Catapult but we still think it is a long way short of the company’s true value.

What does Catapult’s future look like?

The company’s FY 2024 results were a standout, with Forager noting over 40% of the revenue growth “translated to incremental profit”.

“The growth should be similar in 2025 and management expects that incremental profitability to increase further”, it added.

For FY 2025, the ASX All Ords stock’s management said in the last earnings that it aims to sustain strong ACV growth and high retention rates.

The company plans to align with the Rule of 40 – a key valuation metric for SaaS companies – which combines revenue growth rate and profit margin. Catapult achieved a 43% rate last quarter, exceeding the 40% benchmark. It looks to maintain this next year.

Foolish takeaway: ASX All Ords stock with growth

Despite its substantial share price increase over the past year, this ASX All Ords stock’s strategic initiatives and financial performance suggest there is still considerable room for growth.

The company’s focus on technology, customer retention, and profitability positions it well for continued success. Investors will be watching closely to see how Catapult executes its plans in FY25 and beyond, making it a compelling ASX All Ords stock to keep on your radar.

The post Up 80% in a year, this ASX All Ords stock is a ‘long way short’ of its true value appeared first on The Motley Fool Australia.

More reading

• Why AVITA Medical, Catapult, Meridian Energy, and Telix shares are storming higher today
• Why Catapult, Clarity, Pro Medicus, and Qantas shares are rising today
• 3 ASX All Ords shares smashing new multi-year highs while the market sinks
• Catapult shines: 20% sales growth propels ASX tech stock to new 52-week high

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Group International. The Motley Fool Australia has recommended Catapult Group International. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The Nvidia (NASDAQ: NVDA) stock story keeps getting better, thanks primarily to the incredible demand for the company’s graphics processing units (GPUs) and related technology that enable artificial intelligence (AI) capabilities. It’s not too late to buy shares. Indeed, I just outlined 25 reasons to buy Nvidia stock now.

But there’s a key question worth addressing that doesn’t get much attention: When should you consider selling shares of Nvidia stock?

There are no “right” answers. Investors vary in terms of financial and personal factors. That said, below are three solid reasons for any investor to consider selling shares of Nvidia stock.

1. When CEO Jensen Huang no longer leads the company

Investors should consider selling at least some of their Nvidia shares when Huang no longer leads the company he co-founded in 1993. He reportedly turned 61 earlier this year and seems to love his work, so barring any health issues, he could be at Nvidia’s helm for a good number of years more. To say that Huang will be difficult to replace is an understatement.

Nvidia is many years ahead of the competition in AI-enabling technology thanks to Huang’s foresight. Starting more than a decade ago, he began to steadily use profits from Nvidia’s once-core computer gaming business to position the company to be in the catbird seat when the “AI Age” truly arrived. And arrive it did in late 2022, when generative AI made a big splash on the tech scene with OpenAI’s release of its ChatGPT chatbot. Generative AI greatly expands the potential applications for AI.

2. If and when the company’s GPUs seem to be losing their AI-enabling “gold standard” status

A more exact (but too long) subheading is the above plus the following tacked on: “And if the company fails to develop whatever tech is knocking its GPUs from their lofty position.”

Nvidia’s GPUs are by far the favored chips for speeding up the training of AI models and the running of AI applications in data centers. Estimates vary, but it’s widely projected that the company has more than a 90% share of the market for AI GPU chips for data centers, and more than an 80% share of the overall data center AI chip market.

This is a fantastic market to control. Advanced Micro Devices CEO Lisa Su projects that the global data center AI chip market will reach $400 billion in revenue by 2027, which would equate to a compound annual growth rate (CAGR) of more than 72% from its estimated size of $45 billion in 2023.

Nvidia’s data center business accounted for about 87% of its total revenue last quarter, and some greater (but unknown) percentage of its total profits. So, investors should consider selling shares if signs start pointing to the company’s tech being displaced as the gold standard for enabling AI processing in data centers.

How will we know? What signs will there be?

Other than staying abreast of the general space, there are two specific things investors can do. First, listen to Nvidia’s quarterly earnings calls. Besides being interesting, Huang and CFO Colette Kress are very forthright. Recordings of these calls are posted on Nvidia’s investor relations site, so you can listen at your leisure.

Second, monitor Nvidia’s margins — gross, operating, and profit, with special attention to gross margin. A company’s margins will steadily decline when it’s losing its competitive advantages. The key word is “steadily.” Occasional short-term declines or ups and downs aren’t usually reason for concern.

Below is Nvidia’s 10-year margin history. There are ups and downs, but the overall trend has been decisively up. This is a winner of a margin profile chart. (I used trailing-12-month margins for all three margin types because this smooths out some of the quarterly ups and downs. But you can also use quarterly data, as that might be easier.)

Data by YCharts. Gross margin = gross profit/revenue. Operating margin = operating income/revenue. Profit margin = net income/revenue. Gross profit, operating income, net income, and revenue can all be found on a company’s quarterly income statements.

3. To rebalance your investment portfolio

Nvidia stock has performed amazingly well over the long term, and particularly since 2023. So, in the last year and a half, it has no doubt grown to account for a much larger percentage of many investors’ total portfolios.

No matter how terrific a company, it’s risky to have too many of your eggs in one basket. That’s especially true with technology stocks, which tend to be inherently more volatile than stocks of companies in more stable industries.

So, it makes good sense for investors to regularly — perhaps, quarterly or annually — rebalance their portfolio so no single stock becomes too large a holding relative to their total investments. “Too large” is highly subjective, so you’ll have to decide what percentage range you’re comfortable with. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Nvidia stock is still a great buy — but when should investors sell shares? appeared first on The Motley Fool Australia.

More reading

• Prediction: This will be Nvidia’s next big move
• Is Nvidia stock a buy after the 10-for-1 stock split?
• Will Apple stock be worth more than Nvidia by 2025?
• Is Nvidia going to $5 trillion after its 10-for-1 stock split?
• 4 top ASX 200 stocks to buy now for the AI revolution

Beth McKenna has positions in Nvidia. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Advanced Micro Devices and Nvidia. The Motley Fool Australia has recommended Advanced Micro Devices and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

If you are lucky enough to have $10,000 burning a hole in your pocket, then it could be worth putting it to work in the share market.

But would Woolworths Group Ltd (ASX: WOW) shares be a good option for these funds? Let’s see what an investment today could potentially turn into in one year.

Investing $10,000 into Woolworths shares

At present, the supermarket giant’s shares are changing hands for $32.50.

This means that if you were to invest $10,000 (and a further $10), you would end up owning 308 Woolworths shares.

Let’s now see what these shares could be worth this time next year.

According to a recent note out of Goldman Sachs, its analysts believe that now could be a great time to invest in the retailer.

In fact, your $10,000 investment could become worth significantly more if the broker is on the money with its recommendation.

It currently has a conviction buy rating and $39.40 price target on Woolies shares. If they were to rise to that level, those 308 units would have a market value of $12,135.20. That’s over $2,000 more than your original investment.

But wait, there’s more! Every six months, Woolworths shares a portion of its profits with shareholders in the form of dividends.

Goldman is expecting the company to pay fully franked dividends of $1.08 per share in FY 2024 and then $1.14 per share in FY 2025.

Let’s assume that this means dividends of $1.11 per share over the next 12 months (the final dividend of FY 2024 and the interim dividend of FY 2025). This would mean dividend income of $341.88 from those 308 shares.

In total, this brings the total return on investment to approximately $2,650.

Why invest?

Goldman believes that Woolworths shares are being undervalued by the market. Particularly given its It explains:

WOW is the largest supermarket chain in Australia with an additional presence in NZ, as well as selling general merchandise retail via Big W. We are Buy rated on the stock as we believe the business has among the highest consumer stickiness and loyalty among peers, and hence has strong ability to drive market share gains via its omni-channel advantage, as well as its ability to pass through any cost inflation to protect its margins, beyond market expectations. The stock is trading below its historical average (since 2018), and we see this as a value entry level for a high-quality and defensive stock.

The post How much could a $10,000 investment in Woolworths shares become in one year? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Friday
• What is boosting the Treasury Wine share price on Thursday?
• Are Woolworths shares a bargain after falling 20%?
• If I buy 1,000 ANZ shares, how much passive income will I receive?
• Why QBE shares could deliver huge returns for investors that buy them today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.